Education
-
George Washington University Law School, J.D., 2008
-
University of Ulster, United Kingdom, Ph.D., Biomedical Sciences, 2003
-
University of Ulster, United Kingdom, B.Sc., Hons, 1st Class, Biomedical Sciences, 1998
Bar Admissions
-
Virginia
-
U.S. Patent and Trademark Office
|
|
| |
John McKeague applies his technical and legal knowledge to assist clients with complex issues involving intellectual property focusing on biotechnology and life sciences.
Dr. McKeague helps clients avoid and resolve problems associated with the protection and commercialization of IP, including litigation, patent prosecution, licensing, freedom to operate and validity issues. Before rejoining the firm, he served as a patent law clerk at another law firm where he performed various tasks related to patent prosecution, such as drafting patent applications, responding to office actions and corresponding with foreign patent prosecution counsel. The matters Dr. McKeague worked on included complex biotechnology, such as recombinant antibodies, transgenic plants and hormone therapy. He also has prosecuted patents and drafted applications in the fields of medical devices, pharmaceutical formulations, stem cells, video cameras and recombinant blood proteins. In addition, Dr. McKeague has experience related to patent litigation in both federal district court and the U.S. International Trade Commission, due diligence and freedom to operate opinion work in the areas of nucleic acid detection, stem cells, bacterial fermentation technology, software, nutritional supplements and force protection structures.
Dr. McKeague’s past research includes extensive experience in the areas of stem cell biology and cancer biology, as well as basic biotechnology. As a biologist at the National Human Genome Research Institute within the National Institute of Health, he was involved in setting up a cell sorter for aseptic stem cell sorting based on cell surface marker expression, and assisting in immunophenotyping for clinical and nonclinical samples in gene therapy trials.
During his time at the American Red Cross Holland Laboratory in Maryland, Dr. McKeague conducted research with human hematopoietic stem cells and mouse embryonic stem cells, including viral vector mediated genetic manipulation. He also has extensive research experience in cancer research, including his doctorate at the University of Ulster in Northern Ireland.
Dr. McKeague has assisted government working groups charged with assessing and improving research quality and retainment in the UK. As a result, he was an invited participant in a 2001 discussion and meeting with Prime Minister Tony Blair as part of a review and celebration of research excellence within the UK industry and academia. He has taken part in workshops and seminars for commercializing research in the UK and Europe, and has received awards in the areas of immunology and science entrepreneurship.
|
|
|